Lactic Acid

isocitrate dehydrogenase (NADP(+)) 1 ; Homo sapiens







11 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 31960518 Metabolic changes related to the IDH1 mutation in gliomas preserve TCA-cycle activity: An investigation at the protein level. 2020 Mar 3
2 32646946 Lower Lactate Levels and Lower Intracellular pH in Patients with IDH-Mutant versus Wild-Type Gliomas. 2020 Aug 3
3 33778723 Comparative Value of 2-Hydroxyglutarate-to-Lipid and Lactate Ratio versus 2-Hydroxyglutarate Concentration on MR Spectroscopic Images for Predicting Isocitrate Dehydrogenase Mutation Status in Gliomas. 2020 Jul 3
4 29662077 Pharmacodynamics of mutant-IDH1 inhibitors in glioma patients probed by in vivo 3D MRS imaging of 2-hydroxyglutarate. 2018 Apr 16 1
5 28578659 Rapamycin (mTORC1 inhibitor) reduces the production of lactate and 2-hydroxyglutarate oncometabolites in IDH1 mutant fibrosarcoma cells. 2017 Jun 2 2
6 27144334 Mutant IDH1 expression is associated with down-regulation of monocarboxylate transporters. 2016 Jun 7 1
7 27437179 Hyperpolarized (13)C MR imaging detects no lactate production in mutant IDH1 gliomas: Implications for diagnosis and response monitoring. 2016 2
8 25251602 Metabolomic comparison between cells over-expressing isocitrate dehydrogenase 1 and 2 mutants and the effects of an inhibitor on the metabolism. 2015 Jan 1
9 25706986 Metabolic reprogramming in mutant IDH1 glioma cells. 2015 1
10 23456655 GC/MS-based metabolomic analysis of cerebrospinal fluid (CSF) from glioma patients. 2013 May 1
11 6089434 [The effect of impairment of neuroregulation on the activity of redox enzymes in the smooth muscles of the pigeon stomach]. 1984 May-Jun 1